Literature DB >> 27974643

Increased total sodium concentration in gray matter better explains cognition than atrophy in MS.

Adil Maarouf1, Bertrand Audoin2, Fanelly Pariollaud2, Soraya Gherib2, Audrey Rico2, Elisabeth Soulier2, Sylviane Confort-Gouny2, Maxime Guye2, Lothar Schad2, Jean Pelletier2, Jean-Philippe Ranjeva2, Wafaa Zaaraoui2.   

Abstract

OBJECTIVE: To investigate whether brain total sodium accumulation assessed by 23Na MRI is associated with cognitive deficit in relapsing-remitting multiple sclerosis (RRMS).
METHODS: Eighty-nine participants were enrolled in the study (58 patients with RRMS with a disease duration ≤10 years and 31 matched healthy controls). Patients were classified as cognitively impaired if they failed at least 2 tasks on the Brief Repeatable Battery. MRI was performed at 3T using 23Na MRI to obtain total sodium concentration (TSC) in the different brain compartments (lesions, normal-appearing white matter [NAWM], gray matter [GM]) and 1H- magnetization-prepared rapid gradient echo to assess GM atrophy (GM fraction).
RESULTS: The mean disease duration was 3.1 years and the median Expanded Disability Status Scale score was 1 (range 0-4.5). Thirty-seven patients were classified as cognitively preserved and 21 as cognitively impaired. TSC was increased in GM and NAWM in cognitively impaired patients compared to cognitively preserved patients and healthy controls. Voxel-wise analysis demonstrated that sodium accumulation was mainly located in the neocortex in cognitively impaired patients. Regression analysis evidenced than the 2 best independent predictors of cognitive impairment were GM TSC and age. Receiver operating characteristic analyses demonstrated that sensitivity and specificity of the GM TSC to classify patients according to their cognitive status were 76% and 71%, respectively.
CONCLUSIONS: This study provides 2 main findings. (1) In RRMS, total sodium accumulation in the GM is better associated with cognitive impairment than GM atrophy; and (2) total sodium accumulation in patients with cognitive impairment is mainly located in the neocortex.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27974643     DOI: 10.1212/WNL.0000000000003511

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Tissue sodium concentration and sodium T1 mapping of the human brain at 3 T using a Variable Flip Angle method.

Authors:  Arthur Coste; Fawzi Boumezbeur; Alexandre Vignaud; Guillaume Madelin; Kathrin Reetz; Denis Le Bihan; Cécile Rabrait-Lerman; Sandro Romanzetti
Journal:  Magn Reson Imaging       Date:  2019-01-26       Impact factor: 2.546

2.  Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.

Authors:  Wallace J Brownlee; Bhavana Solanky; Ferran Prados; Marios Yiannakas; Patricia Da Mota; Frank Riemer; Manuel Jorge Cardoso; Sebastian Ourselin; Xavier Golay; Claudia Gandini Wheeler-Kingshott; Olga Ciccarelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-04-04       Impact factor: 10.154

Review 3.  Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis.

Authors:  Matilde Inglese; Lazar Fleysher; Niels Oesingmann; Maria Petracca
Journal:  Expert Rev Neurother       Date:  2018-01-30       Impact factor: 4.618

4.  Quantitative Sodium (23Na) MRI in Pediatric Gliomas: Initial Experience.

Authors:  Aashim Bhatia; Vincent Kyu Lee; Yongxian Qian; Michael J Paldino; Rafael Ceschin; Jasmine Hect; James M Mountz; Dandan Sun; Gary Kohanbash; Ian F Pollack; Regina I Jakacki; Fernando Boada; Ashok Panigrahy
Journal:  Diagnostics (Basel)       Date:  2022-05-13

5.  Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event.

Authors:  Sara Collorone; Ferran Prados; Baris Kanber; Niamh M Cawley; Carmen Tur; Francesco Grussu; Bhavana S Solanky; Marios Yiannakas; Indran Davagnanam; Claudia A M Gandini Wheeler-Kingshott; Frederik Barkhof; Olga Ciccarelli; Ahmed T Toosy
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

6.  Measuring tissue sodium concentration: Cross-vendor repeatability and reproducibility of 23 Na-MRI across two sites.

Authors:  Frank Riemer; Damien McHugh; Fulvio Zaccagna; Daniel Lewis; Mary A McLean; Martin J Graves; Fiona J Gilbert; Geoff J M Parker; Ferdia A Gallagher
Journal:  J Magn Reson Imaging       Date:  2019-03-12       Impact factor: 4.813

Review 7.  Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in.

Authors:  Jeroen Van Schependom; Kaat Guldolf; Marie Béatrice D'hooghe; Guy Nagels; Miguel D'haeseleer
Journal:  Transl Neurodegener       Date:  2019-12-09       Impact factor: 8.014

Review 8.  Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice.

Authors:  Nicolo' Bruschi; Giacomo Boffa; Matilde Inglese
Journal:  Eur Radiol Exp       Date:  2020-10-22

Review 9.  Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis.

Authors:  Maria Petracca; Giuseppe Pontillo; Marcello Moccia; Antonio Carotenuto; Sirio Cocozza; Roberta Lanzillo; Arturo Brunetti; Vincenzo Brescia Morra
Journal:  Brain Sci       Date:  2021-03-09

10.  Sodium Intensity Changes Differ Between Relaxation- and Density-Weighted MRI in Multiple Sclerosis.

Authors:  Robert Stobbe; Annie Boyd; Penelope Smyth; Derek Emery; Diana Valdés Cabrera; Christian Beaulieu
Journal:  Front Neurol       Date:  2021-07-14       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.